[1] Downie ML, Gupta S, Tekman MC, et al.Identification of a locus on the X chromosome linked to familial membranous nephropathy[J]. Kidney Intrenational Reports, 2021, 6(6): 1669-1676. [2] 张萍,汪伟,姚琪,等. 单克隆免疫球蛋白血症患者肾脏损害的临床病理特征[J]. 中华病理学杂志,2020,49(4):348-350. [3] Claudio P.Primary membranous nephropathy: an endless story[J]. Journal of nephrology, 2022, 36(2): 563-574. [4] Jiannan Li, Li J, Zhao Cui, et al.Primary glomerular nephropathy among hospitalized patients in a national database in China[J]. Nephrology, 2018, 33(12): 2173-2181. [5] Xu X, Wang G, Chen N, et al.Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China[J]. J Am Soc Nephrol, 2016, 27(12): 3739-3746. [6] Huh H, Lee H, Lee J, et al.Factors affecting the long-term outcomes of idiopathic membranous nephropathy[J]. BMC Nephrology, 2017, 18(1): 104. [7] Moroni G, Ponticelli C. Secondary Membranous Nephropathy.A Narrative Review[J]. Front Med (Lausanne), 2020, 3(7): 611317. [8] Noble R, Taal MW.Epidemiology and causes of chronic kidney disease[J]. Medicine, 2023, 51(3): 165-169. [9] Xie Z, Dong W, Li Z, et al.Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy:A retrospective cohort study[J]. Nephrology, 2020, 25(3): 219-229. [10] Xiaofan H, Jing X, Chenni G, et al.New risk score for predicting progression of membranous nephropathy[J]. Transl Med, 2019, 17(1): 41. [11] Yap WK, Shih MC, Kuo C, et al.Development and Validation of a Nomogram for Assessing Survival in Patients With Metastatic Lung Cancer Referred for Radiotherapy for Bone Metastases[J]. JAMA Netw Open, 2018, 1(6): e183242. [12] Wei C, He Y, Li T, et al.Correction to: Glomerulosclerosis predicts poor renal outcome in patients with idiopathic membranous nephropathy[J]. International Urology and Nephrology, 2021, 53(3): 505-514. [13] Chen X, Chen Y, Ding X, et al.Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy[J]. Ren Fail, 2019, 41(1): 363-369. [14] Kim Y, Yoon HE, Chung BH, et al.Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy[J]. Korean J Intern Med, 2019, 34(5): 1091-1099. [15] 闵柳畅,雷静,何平,等.特发性膜性肾病患者高尿酸血症患病率及相关危险因素分析[J]. 中国中西医结合肾病杂志,2021,22(9):794-796. [16] Muruganantham B, Gopalakrishnan N, Dinesh Kumar T, et al.Clinical outcome of idiopathic membranous nephropathy-a single centre study[J]. The Journal of the Association of Physicians of India, 2022, 70(3): 11-12. [17] 倪丽,石咏军,刘珍珍,等. 影响特发性膜性肾病患者预后的危险因素分析[J]. 中国中西医结合肾病杂志,2018,19(4): 321-323. [18] Lu W, Gong S, Li J, et al.Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension[J]. Exp Ther Med, 2020, 19(4): 2615-2621. [19] Li J, Chen B, Gao C, et al.Clinical and pathological features of idiopathic membranous nephropathy with focal segment sclerosis[J]. BMC nephrology, 2019, 20(1): 467. [20] 陈嘉,程媛,胡豪飞,等. 伴高血压的特发性膜性肾病临床病理特点及预后分析[J].中国中西医结合肾病杂志,2021,22(8):677-681. |